Related Experiment Video
Updated: Sep 24, 2025
A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
Reduction in hemodialysis catheter-related bloodstream infections after implementation of a novel care program
Kai-Ni Lee1,2, Chien-An Chen2,3, Chia-Hui Wu4
1Graduate Institute of Nursing, College of Nursing, Kaohsiung Medical University, Kaohsiung, Taiwan.
Insights
A new care program significantly reduced catheter-related bloodstream infections (CRBSI) in hemodialysis patients with temporary femoral catheters by 82.6%. This intervention improves patient safety and reduces healthcare costs associated with dialysis complications.
Area of Science:
- Nephrology
- Infectious Diseases
- Patient Safety
Background:
- Catheter-related bloodstream infections (CRBSI) are a major cause of morbidity and mortality in hemodialysis patients.
- CRBSI leads to increased healthcare costs and adverse patient outcomes.
- Temporary femoral catheters are commonly used in dialysis, posing a risk for infection.
Purpose of the Study:
- To evaluate the effectiveness of a novel care program in reducing CRBSI rates.
- To assess the impact of the intervention on patients undergoing hemodialysis with temporary femoral catheters.
Main Methods:
- A pre-intervention and post-intervention study design was employed.
- Data was collected from July 2018 to September 2019, with the intervention starting December 1, 2018.
- CRBSI rates per 1000 catheter-days were compared between the baseline and novel care periods.
Main Results:
- The CRBSI rate decreased by 82.63%, from 8.52 to 1.48 per 1000 catheter-days (p=0.036).
- The study included 72 patients, with 33 in the baseline and 39 in the novel care period.
- Coagulase-negative staphylococcus and Burkholderia cepacia were the most frequent pathogens.
Conclusions:
- The novel care program effectively reduced CRBSI incidence in hemodialysis patients with temporary femoral catheters.
- Implementing this program can enhance patient safety and potentially lower treatment costs.
Background:
Catheter-related bloodstream infection (CRBSI) due to dialysis is the major factor causing morbidity and mortality factor for patients undergoing hemodialysis and is associated with additional costs for these patients. This study investigated the effect of a novel care program in terms of reducing CRBSIs for hemodialysis patients with nontunneled (temporary) catheters inserted in their femoral veins.
Methods:
This study included dialysis patients (inpatients and outpatients) from July 2018 to September 2019, covering two periods, pre-intervention (baseline period) and intervention with a novel care program (novel care period). The novel care program was initiated on December 1, 2018. The CRBSI rates (/1000 catheter-days) for the baseline and novel care periods were compared, and the characteristics of the pathogens were determined.
Findings:
Of a total of 72 patients, 33 were from the baseline period and 39 were from the novel care period. Patients in the baseline and novel care periods had the catheter inserted in their femoral veins for a median of 20 and 29 days, respectively. The CRBSI rate decreased by 82.63%, from 8.52/1000 catheter-days in the baseline period to 1.48/1000 catheter-days in the novel care period (p = 0.036). The most common organisms involved in CRBSIs were coagulase-negative staphylococcus and Burkholderia cepacia (26% for both).
Discussion:
The novel care program reduced the incidence of CRBSIs in patients with temporary catheters inserted in their femoral veins.
Related Concept Videos
01:24Hemodialysis II: Procedure and Complications
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:25Hemodialysis I: Introduction
01:25Hemodialysis III: Nursing Management
01:30Continuous Renal Replacement Therapy
01:29Endocarditis IV: Nursing Management